Clinical Trials · NCT03031535

Study of Intranasal Octreotide (DP1038) in Healthy Adult Volunteers

Name: Study of Intranasal Octreotide (DP1038) in Healthy Adult Volunteers
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

CompletedPhase 1Octreotide Sermorelin

Phase: Phase 1
Recruitment status: Completed
Sponsor: Dauntless Pharmaceuticals
Enrollment: 32
Start date: Jan 2017
Locations: 1 site, United States
Primary endpoint: Percentage of subjects reporting adverse events (AEs)/serious adverse events (SAEs).

View Octreotide compound reference